The most recently added documents are listed below. To narrow down the results into the key area you are interested in, select the relevant term and press search. You can narrow the results further by selecting more terms. Untick a selected box to remove that filter or click reset to start over.
The study aims to (a) identify future trachoma mapping needs in the Pacific and (b) to examine whether any temporal trends in trachoma prevalence could be ascertained from the historical literature on trachoma in the Pacific Islands.
This article reports findings from an infant adverse event survey in 1–5 month olds who received azithromycin as part of a large community-randomized trial in Niger.
Key messages for the WHO Eastern Mediterranean Region from the 2018 GET2020 database as at 17 April 2018
This document presents (i) the principles important to the design of trachoma prevalence surveys conducted after interventions intended to eliminate the disease as a public health problem, and (ii) WHO recommendations for their implementation.
This study used methodologies and systems for trachoma surveys considered to represent international best practice in order to generate reliable estimates of the prevalence of trachoma.
This article looks at the contribution of Helen Keller International and its work to build the capacity of Ministries of Health to conduct community mobilization, mass drug administration campaigns, morbidity management, monitoring and evaluation for neglected tropical diseases.
This study explores the relationship between TF and PCR throughout an elimination program and a sero-catalytic model to evaluate the utility of two cross-sectional sero-surveys for estimating sero-conversion rates.
This study assessed several methods for identifying a core group for trachoma, assuming varying degrees of knowledge about the transmission process.
This systematic review synthesises evidence on the emergence of antimicrobial resistance after mass azithromycin distribution.